These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3573463)

  • 1. [Chemotherapy of renal cell carcinoma. II. Adriamycin and carboquone combined chemotherapy].
    Osawa T
    Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1805-13. PubMed ID: 3573463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination chemotherapy with adriamycin, carboquone and 5-Fu for bladder cancer].
    Uchibayashi T; Hisazumi H; Saitoh Y; Naitoh K; Misaki T; Nango C; Tajiri S; Nakamura T; Kojima A; Mikawa I
    Hinyokika Kiyo; 1983 Dec; 29(12):1617-23. PubMed ID: 6677109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of vinblastine and doxorubicin in advanced renal cell carcinoma.
    Jekunen A; Stengård J; Pyrhönen S
    Eur J Cancer; 1994; 30A(2):245. PubMed ID: 8155397
    [No Abstract]   [Full Text] [Related]  

  • 4. [A combined chemo-endocrine therapy of advanced renal cell carcinoma].
    Wada T; Yasutomi M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2294-8. PubMed ID: 3128617
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma.
    Rashid MH; Welsh CT; Bissada NK; Chaudhary UB
    Am J Clin Oncol; 2005 Feb; 28(1):107-8. PubMed ID: 15685046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
    Masuda F; Nakada J; Kondo I; Furuta N
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2143-6. PubMed ID: 1888185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of combination chemotherapy with dacarbazine, cyclophosphamide, cisplatin, doxorubicin, and vindesine (DECAV) in advanced renal cell cancer.
    Lupera H; Theodore C; Ghosn M; Court BH; Wibault P; Droz JP
    Urology; 1989 Nov; 34(5):281-3. PubMed ID: 2815451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.
    Yagoda A
    Prog Clin Biol Res; 1990; 350():227-41. PubMed ID: 2201045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
    Okumura S; Nishimura T; Yoshida K; Ohhara M; Hasegawa J; Hirasawa S; Hara M; Kawamura N; Kanamori S; Akimoto M
    Hinyokika Kiyo; 1984 Sep; 30(9):1167-71. PubMed ID: 6084420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma.
    Wada T; Houjou T; Kubo R; Yasutomi M; Kurita T
    Anticancer Res; 1993; 13(6B):2465-7. PubMed ID: 8135483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy by bronchial arterial infusion for pulmonary metastases of renal cell carcinoma.
    Kakizoe T; Matsumoto K; Nishio Y; Ohtani M; Miyazawa N
    J Urol; 1984 Jun; 131(6):1053-5. PubMed ID: 6427476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on the effects of chemotherapy as treatment of renal cell carcinoma].
    Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):43-9. PubMed ID: 3379331
    [No Abstract]   [Full Text] [Related]  

  • 13. [A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma].
    Wada T; Morikawa E; Yasutomi M; Takagi H; Aizawa M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1652-6. PubMed ID: 2230447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials Group.
    Schwartsmann G; Medina de Cunha F; Silveira LA; Salgado G; Thereza MS; Vinholes J; Preger P; Segal F
    Ann Oncol; 1991 Jun; 2(6):443. PubMed ID: 1768632
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylactic intravesical chemotherapy in bladder tumors after surgery of upper tract urothelial carcinoma].
    Tari K; Satake I; Kojima S; Negishi T; Yoshida K; Nakame Y; Kanaoya F; Horiuchi S; Saito T; Owada F
    Hinyokika Kiyo; 1987 Jun; 33(6):852-6. PubMed ID: 3118664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot phase II trial of amphotericin B and CCNU in renal and colorectal carcinomas.
    Presant CA; Kennedy P; Wiseman C; Gala K; Smith JD; Bouzaglou A; Farbstein M; Multhauf P; Bertrand M; Green L
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):329-30. PubMed ID: 3709601
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of oral ftorafur and uracil in patients with advanced renal cell carcinoma.
    Esteban E; Buesa JM; Cueva J; Fernández Y; Peláez I; Fernández JL; Sanz A; Palacio I; Estrada E; Gracia JM
    Eur J Cancer; 1993; 29A(9):1354. PubMed ID: 8343285
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical effect of UFT in advanced renal cell carcinoma].
    Hoshino M; Inoue K; Higaki M; Imamura K
    Hinyokika Kiyo; 1988 Mar; 34(3):538-40. PubMed ID: 3133935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circumvention of the multidrug-resistance in renal cancer by bisbenzylisoquinoline].
    Kakehi Y; Hashimura T; Yoshida O; Segawa T; Kanematsu A
    Hinyokika Kiyo; 1993 Dec; 39(12):1227-32. PubMed ID: 8285174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemotherapy of metastatic renal cell carcinoma: report of 28 cases.
    Wang HJ; Chen HX; Li HZ
    Chin Med J (Engl); 2005 Jan; 118(2):172-3. PubMed ID: 15667805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.